Dr Jacqueline Tearle
Jacqueline completed her Ph.D. at EMBL Australia node in Single Molecule Science, UNSW, under the supervision of A/Prof. Maté Biro, where she used live-cell microscopy and single cell transcriptomics to investigate tumour escape and invasion in melanoma. She joined Garvan in 2022 as a Postdoctoral Researcher in the Gut Immunogenomics group, headed by Dr. Kylie James. Jac’s current research involves using single cell transcriptomics and computational techniques to characterise cellular and microbial drivers of intestinal disease.
Awards
- 2024Tour de Cure Early Career Research Grant
- 2023EMBL Corporate Partnership Programme Fellowship
- 2023EMBL Fee Waiver Grant
- 2017UNSW Tuition Fee Scholarship 2017-2021
- 2015University of Birmingham Masters Scholarship
- 2012University of Birmingham Chamberlain Award
Selected publications
See all publications- 2023Cancer Research Communications10.1158/2767-9764.CRC-22-0305
Targeted Single-cell Isolation of Spontaneously Escaping Live Melanoma Cells for Comparative Transcriptomics.
- 2023Mucosal Immunology10.1016/j.mucimm.2023.11.004
Role reversals: non-canonical roles for immune and non-immune cells in the gut.
- 2020Journal of Cell Science10.1242/jcs.238014
The Lifeact-EGFP mouse is a translationally controlled fluorescent reporter of T cell activation.